The approval of Blue Earth Diagnostics' Posluma (flotufolastat F 18) is a significant step forward for PSMA PET imaging, but will it actually help improve patient outcomes?
Brian F. Chapin, M.D.
Advertisement
Articles by Brian F. Chapin, M.D.
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on Diagnostic Imaging
1
FDA Clears AI-Powered Platform for Converting Spine MRIs to 3D Visualizations
2
Diagnostic Imaging’s Weekly Scan: October 4 — October 10
3
The Reading Room Podcast: Current Perspectives, Challenges and Possibilities with AI in Breast Imaging, Part 3
4
What New Dosimetry Data Reveals About 177Lu-Edotreotide for GEP-NET Treatment
5